Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-
modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …

Abstract Purpose of Review To review the impact of disease-modifying antirheumatic drugs
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …

After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

Objective The effect of the COVID‐19 pandemic on community‐based rheumatology care
and the use of telehealth is unclear. We undertook this study to investigate the impact of the …

Rheumatoid arthritis (RA) patients face different health challenges when infected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than the general …

The objectives of the study were to review the articles to identify (a) the epidemiology of
systemic lupus erythematosus (SLE) and coronavirus disease 2019 (COVID-19);(b) the …

Objectives The COVID-19 pandemic has serious social, economic and health
consequences. Particularly in these times, it is important to maintain individual health …

Background Previous models that assess quality-of-Life (QoL) in patients with rheumatic
diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related …

Introduction The COVID‐19 pandemic led to rapid and widespread adoption of telemedicine
in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) …